Newstral
Article
Mmarketwatch.com on 2018-05-16 16:11
Iterum Therapeutics sets terms of IPO, to raise up to $85 million
Related news
- MForma Therapeutics sets terms for IPO, could raise up to $212 millionmarketwatch.com
- MKeros Therapeutics sets IPO terms, expects to raise up to $80 millionmarketwatch.com
- MSmileDirectClub sets IPO terms to raise up to $1.3 billionmarketwatch.com
- MEndeavor sets IPO terms, to raise up to $619 millionmarketwatch.com
- MConstruction Partners sets terms of IPO to raisemarketwatch.com
- MImmunome sets IPO terms, to raise up to $32.5 millionmarketwatch.com
- MCactus sets IPO terms to raise up to $407 millionmarketwatch.com
- MOneWater sets IPO terms to raise up to $63.2 millionmarketwatch.com
- MDun & Bradstreet sets IPO terms, to raise nearly $1.4 billionmarketwatch.com
- MKaruna Therapeutics sets IPO terms, to be valued at up to $363 millionmarketwatch.com
- MRubius Therapeutics sets terms of IPO, which could value the company at up to $1.7 billionmarketwatch.com
- MNurix Therapeutics sets IPO terms, to be valued at up to $627 millionmarketwatch.com
- MRelay Therapeutics sets IPO terms, to be valued at up to $1.5 billionmarketwatch.com
- MITeos Therapeutics sets IPO terms, to value the company at up to $571.5 millionmarketwatch.com
- MADC Therapeutics sets IPO terms, to be valued at up to $1 billionmarketwatch.com
- Audentes Therapeutics sets IPO price targets, hopes to raise up to $92Mbizjournals.com
- S.F.'s Audentes Therapeutics sets IPO price targets, hopes to raise up to $92Mbizjournals.com
- AppDynamics Sets Terms for IPOwsj.com
- MDova Pharmaceuticals sets IPO terms to raise $69.1 million before optionsmarketwatch.com
- MBayCom sets terms of IPO, to offer 2.3 million shares to raise up to $52.3 millionmarketwatch.com